{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:53:42Z","timestamp":1791672822911,"version":"4.3.4"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hearing Research"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.heares.2021.108209","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T04:32:42Z","timestamp":1613881962000},"page":"108209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Development of ebselen for the treatment of sensorineural hearing loss and tinnitus"],"prefix":"10.1016","volume":"413","author":[{"given":"Jonathan","family":"Kil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Emily","family":"Harruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Longenecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.heares.2021.108209_bib0001","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00002512-200421050-00002","article-title":"Tinnitus in the older adult: epidemiology, pathophysiology and treatment options","volume":"21","author":"Ahmad","year":"2004","journal-title":"Drugs Aging"},{"key":"10.1016\/j.heares.2021.108209_bib0002","doi-asserted-by":"crossref","unstructured":"American Speech-Language-Hearing Association, 1994. Audiologic management of individuals receiving cochleotoxic drug therapy [Guidelines]. Available from www.asha.org\/policy. doi: 10.1044\/policy.GL1994-00003","DOI":"10.1044\/policy.GL1994-00003"},{"key":"10.1016\/j.heares.2021.108209_bib0003","doi-asserted-by":"crossref","first-page":"H1431","DOI":"10.1152\/ajpheart.00504.2016","article-title":"Ebselen does not improve oxidative stress and vascular function in patients with diabetes: a randomized, crossover trial","volume":"311","author":"Beckman","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"203","key":"10.1016\/j.heares.2021.108209_bib0004","first-page":"5","article-title":"Changes in the response properties of inferior colliculus neurons relating to tinnitus","author":"Berger","year":"2014","journal-title":"Front. Neurol."},{"issue":"10","key":"10.1016\/j.heares.2021.108209_bib0005","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamaoto.2016.1700","article-title":"Prevalence, severity, exposures, and treatment patterns of tinnitus in the United States","volume":"142","author":"Bhatt","year":"2016","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"issue":"1","key":"10.1016\/j.heares.2021.108209_bib0006","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/s41467-017-01837-1","article-title":"Cisplatin is retained in the cochlea indefinitely following chemotherapy","volume":"8","author":"Breglio","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heares.2021.108209_bib0007","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.neuron.2014.07.028","article-title":"Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia","volume":"83","author":"Cabungcal","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.heares.2021.108209_bib0008","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.heares.2016.08.009","article-title":"Auditory thalamic circuits and GABAA receptor function: putative mechanisms in tinnitus pathology","volume":"349","author":"Caspary","year":"2017","journal-title":"Hear. Res."},{"issue":"4","key":"10.1016\/j.heares.2021.108209_bib0009","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/14728214.2018.1555240","article-title":"An update: emerging drugs for tinnitus","volume":"23","author":"Cederroth","year":"2018","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.heares.2021.108209_bib0010","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neuroscience.2015.12.005","article-title":"Noise trauma induced plastic changes in brain regions outside the classical auditory pathway","volume":"315","author":"Chen","year":"2016","journal-title":"J. Neurosci."},{"issue":"564","key":"10.1016\/j.heares.2021.108209_bib0011","doi-asserted-by":"crossref","first-page":"eabb2830","DOI":"10.1126\/scitranslmed.abb2830","article-title":"Bimodal neuromodulation combining sound and tonge stimulation reduces tinnitus symptoms in a large randomized clinical study","volume":"12","author":"Conlon","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"124","key":"10.1016\/j.heares.2021.108209_bib0012","article-title":"Thalamocortical dysrhythmia: a theoretical update in tinnitus","volume":"6","author":"De Ridder","year":"2015","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.heares.2021.108209_bib0013","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3766\/jaaa.21.6.6","article-title":"Tinnitus onset rates from chemotherapeutic agents and ototoxic antibiotics: results of a large prospective study","volume":"21","author":"Dille","year":"2010","journal-title":"J. Am. Acad. Audiol."},{"issue":"29","key":"10.1016\/j.heares.2021.108209_bib0014","article-title":"Maladaptive neural synchrony in tinnitus: origin and restoration","volume":"6","author":"Eggermont.","year":"2015","journal-title":"Front. Neurol."},{"issue":"7332","key":"10.1016\/j.heares.2021.108209_bib0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature09656","article-title":"Reversing pathological neural activity using targeted plasticity","volume":"470","author":"Engineer","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.heares.2021.108209_bib0016","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.heares.2021.108209_bib0017","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1121\/1.5132545","article-title":"Inflammation associated with noise-induced hearing loss","volume":"146","author":"Frye","year":"2019","journal-title":"J. Acoust. Soc. Am."},{"key":"10.1016\/j.heares.2021.108209_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.heares.2019.01.022","article-title":"Residual inhibition: from the putative mechanisms to potential tinnitus treatment","volume":"375","author":"Galazyuk","year":"2019","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2021.108209_bib0019","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jcf.2017.01.006","article-title":"The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis","volume":"16","author":"Garinis","year":"2017","journal-title":"J. Cyst. Fibros"},{"issue":"3","key":"10.1016\/j.heares.2021.108209_bib0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0194599816628524","article-title":"2015 equilibrium committee amendment to the 1995 AAO-HNS guidelines for the definition of M\u00e9ni\u00e8re's disease","volume":"154","author":"Goebel","year":"2016","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.heares.2021.108209_bib0021","article-title":"Ebselen attenuates tobramycin-induced ototoxicity in mice","author":"Gu","year":"2020","journal-title":"J. Cyst. Fibros"},{"issue":"sup4","key":"10.1016\/j.heares.2021.108209_bib0022","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1080\/14992027.2018.1455114","article-title":"Protection for medication-induced hearing loss: the state of the science","volume":"57","author":"Hammill","year":"2018","journal-title":"Int. J. Audiol."},{"issue":"5","key":"10.1016\/j.heares.2021.108209_bib0023","doi-asserted-by":"crossref","first-page":"e37733","DOI":"10.1371\/journal.pone.0037733","article-title":"Tinnitus severity is reduced with reduction of depressive mood \u2013 a prospective population study in Sweden","volume":"7","author":"H\u00e9bert","year":"2012","journal-title":"PLoS One"},{"issue":"0","key":"10.1016\/j.heares.2021.108209_bib0024","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.heares.2010.10.011","article-title":"Comparative analysis of combination kanamycin-furosemide versus kanamycin alone in the mouse cochlea","volume":"272","author":"Hirose","year":"2011","journal-title":"Hear. Res."},{"issue":"2","key":"10.1016\/j.heares.2021.108209_bib0025","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5935\/0946-5448.20130022","article-title":"The mismatch negativity test in ears with and without tinnitus-A path to the objectification of tinnitus","volume":"18","author":"Holdefer","year":"2013","journal-title":"Int. Tinnitus J."},{"key":"10.1016\/j.heares.2021.108209_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3989201","article-title":"N-methyl-d-aspartate receptors involvement in the gentamicin-induced hearing loss and pathological changes of ribbon synapse in the mouse cochlea inner hair cells","volume":"2018","author":"Hong","year":"2018","journal-title":"Neural Plast."},{"issue":"308","key":"10.1016\/j.heares.2021.108209_bib0027","article-title":"Aminoglycoside-induced cochleotoxicity: a review","volume":"11","author":"Jiang","year":"2017","journal-title":"Front. Cell Neurosci."},{"issue":"22","key":"10.1016\/j.heares.2021.108209_bib0028","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.1113\/jphysiol.2014.278572","article-title":"Single unit hyperactivity and bursting in the auditory thalamus of awake rats directly correlates with behavioral evidence of tinnitus","volume":"592","author":"Kalappa","year":"2014","journal-title":"J. Physiol."},{"issue":"1-2","key":"10.1016\/j.heares.2021.108209_bib0029","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.heares.2006.08.006","article-title":"Ebselen treatment reduces noise induced hearing loss via the mimicry and induction of glutathione peroxidase","volume":"226","author":"Kil","year":"2007","journal-title":"Hear. Res."},{"issue":"10098","key":"10.1016\/j.heares.2021.108209_bib0030","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(17)31791-9","article-title":"Safety and efficacy of Ebselen for the prevention of noise-induced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"390","author":"Kil","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.heares.2021.108209_bib0031","series-title":"2018 ARO Abstract","article-title":"SPI-1005 a novel investigational drug for the treatment of Meniere's disease","volume":"41","author":"Kil","year":"2018"},{"key":"10.1016\/j.heares.2021.108209_bib0032","series-title":"2018 NACFC Abstract","article-title":"Stop ototoxicity: phase 1\/2 clinical trial of SPI-1005","author":"Kil","year":"2018"},{"key":"10.1016\/j.heares.2021.108209_bib0033","series-title":"2019 ISIET Abstract","article-title":"Phase 2b randomized double blind placebo-controlled trial of SPI-1005 for Meniere's disease","author":"Kil","year":"2019"},{"key":"10.1016\/j.heares.2021.108209_bib0034","series-title":"2019 ARO Abstract","article-title":"Stop ototoxicity: phase 1\/2 clinical trial of SPI-1005 in cystic fibrosis","volume":"42","author":"Kil","year":"2019"},{"issue":"1-2","key":"10.1016\/j.heares.2021.108209_bib0035","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.heares.2009.03.003","article-title":"Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells","volume":"251","author":"Kim","year":"2009","journal-title":"Hear Res."},{"key":"10.1016\/j.heares.2021.108209_bib0036","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.08.002","article-title":"Advances in the neurobiology of hearing disorders: recent developments regarding the basis of tinnitus and hyperacusis","volume":"111","author":"Knipper","year":"2013","journal-title":"Prog. Neurobiol."},{"issue":"38","key":"10.1016\/j.heares.2021.108209_bib0037","doi-asserted-by":"crossref","first-page":"7190","DOI":"10.1523\/JNEUROSCI.1314-19.2020","article-title":"The neural bases of tinnitus: lessons from deafness and cochlear implants","volume":"40","author":"Knipper","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.heares.2021.108209_bib0038","first-page":"559","article-title":"Use of organotypic cultures of corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells","volume":"18","author":"Kopke","year":"1997","journal-title":"Am. J. Otol."},{"issue":"4","key":"10.1016\/j.heares.2021.108209_bib0039","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1517\/14728210903206975","article-title":"Emerging pharmacotherapy of tinnitus","volume":"14","author":"Langguth","year":"2009","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"1","key":"10.1016\/j.heares.2021.108209_bib0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40463-017-0219-x","article-title":"Current insights in noise-induced hearing loss: a literature review of the underlying mechanism, pathophysiology, asymmetry, and management options","volume":"46","author":"Le","year":"2017","journal-title":"J. Otolarnygol. Head Neck Surg."},{"key":"10.1016\/j.heares.2021.108209_bib0041","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.heares.2015.08.005","article-title":"Auditory-limbic interactions in chronic tinnitus: challenges for neuroimaging research","volume":"334","author":"Leaver","year":"2016","journal-title":"Hear. Res."},{"issue":"10","key":"10.1016\/j.heares.2021.108209_bib0042","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1080\/00016480410017521","article-title":"Role of reactive radicals in degeneration of the auditory system of mice following cisplatin treatment","volume":"124","author":"Lee","year":"2004","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.heares.2021.108209_bib0043","series-title":"Oxidative Stress and Antioxidant Protection: The Science of Free Radical Biology & Disease","first-page":"115","article-title":"Disorders of hearing","author":"Le Prell","year":"2016"},{"issue":"3","key":"10.1016\/j.heares.2021.108209_bib0044","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s12035-013-8454-2","article-title":"Cochlear inner hair cell ribbon synapse is the primary target of ototoxic aminoglycoside stimuli","volume":"48","author":"Liu","year":"2013","journal-title":"Mol. Neurobiol."},{"issue":"46","key":"10.1016\/j.heares.2021.108209_bib0045","doi-asserted-by":"crossref","first-page":"16141","DOI":"10.1523\/JNEUROSCI.2499-12.2012","article-title":"Diminished cortical inhibition in an aging mouse model of chronic tinnitus","volume":"32","author":"Llano","year":"2012","journal-title":"J. Neurosci."},{"issue":"207","key":"10.1016\/j.heares.2021.108209_bib0046","article-title":"Variable effects of acoustic trauma on behavioral and neural correlates of tinnitus in individual animals","volume":"10","author":"Longenecker","year":"2016","journal-title":"Front. Behav. Neurosci."},{"issue":"561185","key":"10.1016\/j.heares.2021.108209_bib0047","article-title":"A novel mouse model of aminoglycoside-induced hyperacusis and tinnitus","volume":"14","author":"Longenecker","year":"2020","journal-title":"Front. Neurosci."},{"issue":"01","key":"10.1016\/j.heares.2021.108209_bib0048","doi-asserted-by":"crossref","first-page":"047","DOI":"10.1055\/s-0028-1111106","article-title":"Development of ebselen, a glutathione peroxidase mimic, for the prevention and treatment of noise-induced hearing loss","volume":"30","author":"Lynch","year":"2009","journal-title":"Sem. Hear."},{"issue":"2","key":"10.1016\/j.heares.2021.108209_bib0049","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00005537-200402000-00029","article-title":"Ebselen-mediated protection from single and repeated noise exposure in rat","volume":"114","author":"Lynch","year":"2004","journal-title":"Laryngoscope"},{"issue":"1-2","key":"10.1016\/j.heares.2021.108209_bib0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.heares.2004.08.002","article-title":"Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen","volume":"201","author":"Lynch","year":"2005","journal-title":"Hear. Res."},{"issue":"5","key":"10.1016\/j.heares.2021.108209_bib0051","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00001813-200506000-00013","article-title":"Combined oral delivery of ebselen and allopurinol reduces multiple cisplatin toxicities in rat breast and ovarian cancer models while enhancing anti-tumor activity","volume":"16","author":"Lynch","year":"2005","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.heares.2021.108209_bib0052","series-title":"Translational Research in Audiology, Neurotology, and the Hearing Sciences, Springer Handbook of Auditory Research","first-page":"105","article-title":"Human clinical studies in noise-induced hearing loss","author":"Lynch","year":"2016"},{"key":"10.1016\/j.heares.2021.108209_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.heares.2020.107957","article-title":"Acoustic trauma induced the alteration of the activity of excitatory and inhibitory neurons in the inferior colliculus of mice","volume":"391","author":"Ma","year":"2020","journal-title":"Hear Res."},{"issue":"2","key":"10.1016\/j.heares.2021.108209_bib0054","doi-asserted-by":"crossref","first-page":"317","DOI":"10.5152\/iao.2018.140818","article-title":"European position statement on diagnosis, and treatment of Meniere's disease","volume":"14","author":"Magnan","year":"2018","journal-title":"J. Int. Adv. Otol."},{"issue":"4","key":"10.1016\/j.heares.2021.108209_bib0055","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3766\/jaaa.26.4.8","article-title":"Alterations in auditory change detection associated with tinnitus residual inhibition induced by auditory electrical stimulation","volume":"26","author":"Mahmoudian","year":"2015","journal-title":"J. Am. Acad. Audiol."},{"key":"10.1016\/j.heares.2021.108209_bib0056","doi-asserted-by":"crossref","first-page":"eaal3175","DOI":"10.1126\/scitranslmed.aal3175","article-title":"Auditory-somatosensory bimodal stimulation desynchronizes brain circuitry to reduce tinnitus in guinea pigs and humans","volume":"10","author":"Marks","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"42","key":"10.1016\/j.heares.2021.108209_bib0057","doi-asserted-by":"crossref","first-page":"21198","DOI":"10.1073\/pnas.1914088116","article-title":"Amloid-beta impairs TOM1-mediated IL-1R1 signaling","volume":"116","author":"Martini","year":"2019","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.heares.2021.108209_bib0058","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00213-015-4189-2","article-title":"Effects of the potential lithium-mimetic, ebselen, on brain neurochemistry: a magnetic resonance spectroscopy study at 7 tesla","volume":"233","author":"Masaki","year":"2016","journal-title":"Psychopharmacology"},{"issue":"14","key":"10.1016\/j.heares.2021.108209_bib0059","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1007\/s00213-016-4319-5","article-title":"Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing","volume":"233","author":"Masaki","year":"2016","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.heares.2021.108209_bib0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/AUD.0b013e31822f67c0","article-title":"The tinnitus functional index: development of a new clinical measure for chronic, intrusive tinnitus","volume":"33","author":"Meikle","year":"2012","journal-title":"Ear Hear."},{"key":"10.1016\/j.heares.2021.108209_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.heares.2020.108081","article-title":"The cerebellar (para)flocculus: a review on its auditory function and a possible role in tinnitus","volume":"398","author":"Mennink","year":"2020","journal-title":"Hear. Res."},{"issue":"2","key":"10.1016\/j.heares.2021.108209_bib0062","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/exnr.2000.7516","article-title":"The Antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of parkinson's disease","volume":"166","author":"Moussaoui","year":"2000","journal-title":"Exp. Neurol."},{"issue":"20","key":"10.1016\/j.heares.2021.108209_bib0063","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1016\/0006-2952(84)90083-2","article-title":"A novel biologically active seleno-organic compound\u2013I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen)","volume":"33","author":"M\u00fcller","year":"1984","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.heares.2021.108209_bib0064","doi-asserted-by":"crossref","first-page":"16028","DOI":"10.1038\/nrdp.2016.28","article-title":"Meniere's disease","volume":"2","author":"Nakashima","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.heares.2021.108209_bib0065","unstructured":"NIDCD. Meniere's Disease https:\/\/www.nidcd.nih.gov\/health\/menieres-disease"},{"issue":"2","key":"10.1016\/j.heares.2021.108209_bib0066","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000015908","article-title":"Ebselen in acute middle cerebral artery occlusion: a placebo-controlled, double-blind clinical trial","volume":"9","author":"Ogawa","year":"1999","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.heares.2021.108209_bib0067","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1809394","article-title":"Cisplatin-associated ototoxicity: a review for health professional","author":"Paken","year":"2016","journal-title":"J. Toxicol."},{"key":"10.1016\/j.heares.2021.108209_bib0068","first-page":"1211","article-title":"Effect of ebselen on noise induced cochlear damage","volume":"48","author":"Park","year":"2005","journal-title":"Korean J. Otolaryngol."},{"key":"10.1016\/j.heares.2021.108209_bib0069","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0378-5955(03)00178-3","article-title":"Ebselen attenuates cochlear damage caused by acoustic trauma","volume":"181","author":"Pourbakht","year":"2003","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2021.108209_bib0070","series-title":"Inflammatory Mechanisms in Mediating Hearing Loss","author":"Ramkumar","year":"2018"},{"issue":"10","key":"10.1016\/j.heares.2021.108209_bib0071","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.tics.2015.08.002","article-title":"Frontostriatal gating of tinnitus and chronic pain","volume":"19","author":"Rauschecker","year":"2015","journal-title":"Trends Cogn. Sci."},{"issue":"45","key":"10.1016\/j.heares.2021.108209_bib0072","doi-asserted-by":"crossref","first-page":"14972","DOI":"10.1523\/JNEUROSCI.4028-10.2010","article-title":"Ringing ears: the neuroscience of tinnitus","volume":"30","author":"Roberts","year":"2010","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.heares.2021.108209_bib0073","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1176\/appi.ajp.2017.17040423","article-title":"Sensation and psychiatry: linking age-related hearing loss to late-life depression and cognitive decline","volume":"175","author":"Rutherford","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.heares.2021.108209_bib0074","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1097\/MAO.0000000000001071","article-title":"Temporary and permanent noise-induced threshold shifts: a review of basic and clinical observations","volume":"37","author":"Ryan","year":"2016","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.heares.2021.108209_bib0075","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1097\/00005537-199911000-00003","article-title":"Application of antioxidants and other agents to prevent cisplatin ototoxicity","volume":"109","author":"Rybak","year":"1999","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.heares.2021.108209_bib0076","first-page":"513","article-title":"Effect of protective agents against cisplatin ototoxicity","volume":"21","author":"Rybak","year":"2000","journal-title":"Am. J. Otol."},{"key":"10.1016\/j.heares.2021.108209_bib0077","doi-asserted-by":"crossref","unstructured":"Sakurai T, Kanayama M, Shibata T, et\u00a0al. Ebselen, a seleno-organic antioxidant, as an electrophile [published correction appears in Chem Res Toxicol. 2006 Nov;19(11):1557]. Chem Res Toxicol. 2006;19(9):1196-1204. doi:10.1021\/tx0601105.","DOI":"10.1021\/tx0601105"},{"issue":"2","key":"10.1016\/j.heares.2021.108209_bib0078","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00006123-199802000-00038","article-title":"Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage","volume":"42","author":"Saito","year":"1998","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.heares.2021.108209_bib0079","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/MAO.0000000000002194","article-title":"Hearing protection, restoration, and regeneration: an overview of emerging therapeutics for inner ear and central hearing disorders","volume":"40","author":"Schilder","year":"2019","journal-title":"Oto Neurtolol."},{"key":"10.1016\/j.heares.2021.108209_bib0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.heares.2019.07.003","article-title":"Early phase trials of novel hearing therapuetics: Avenues and opportunities","volume":"380","author":"Schilder","year":"2019","journal-title":"Hear. Res."},{"issue":"2","key":"10.1016\/j.heares.2021.108209_bib0081","doi-asserted-by":"crossref","first-page":"53","DOI":"10.7874\/jao.2020.00115","article-title":"Experimental animal models for Meniere's disease: a mini-review","volume":"24","author":"Seo","year":"2020","journal-title":"J. Audiol. Otol."},{"issue":"1","key":"10.1016\/j.heares.2021.108209_bib0082","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/13543784.2017.1269171","article-title":"Emerging therapeutic interventions against noise-induced hearing loss","volume":"26","author":"Sha","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.heares.2021.108209_bib0083","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-020-05654-1","article-title":"A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania","author":"Sharpley","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.heares.2021.108209_bib0084","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neuron.2019.05.008","article-title":"Mechanisms of noise-induced tinnitus: Insights from cellular studies","volume":"103","author":"Shore","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.heares.2021.108209_bib0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1054-3589(08)60986-2","article-title":"Ebselen as a glutathione peroxidase mimic and as a scavenger of peroxynitrite","volume":"38","author":"Sies","year":"1997","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.heares.2021.108209_bib0086","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/ncomms2320","article-title":"A safe lithium mimetic for bipolar disorder","volume":"4","author":"Singh","year":"2013","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.heares.2021.108209_bib0087","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1038\/npp.2015.343","article-title":"Effect of the putative lithium mimetic ebselen on brain myo-inositol, sleep, and emotional processing in humans","volume":"41","author":"Singh","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.heares.2021.108209_bib0088","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000027643","article-title":"Free radicals in the guinea pig inner ear following gentamicin exposure","volume":"61","author":"Takumida","year":"1999","journal-title":"ORL J. Otorhinolaryngol. Relat. Spec."},{"issue":"6","key":"10.1016\/j.heares.2021.108209_bib0089","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000307","article-title":"Neuroinflammation mediates noise-induced synaptic imbalance and tinnitus in rodent models","volume":"17","author":"Wang","year":"2019","journal-title":"PLoS Biol."},{"issue":"20","key":"10.1016\/j.heares.2021.108209_bib0090","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/0006-2952(84)90084-4","article-title":"A novel biologically active seleno-organic compound\u2013II. Activity of PZ 51 in relation to glutathione peroxidase","volume":"33","author":"Wendel","year":"1984","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.heares.2021.108209_bib0091","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1682\/JRRD.2005.01.0009","article-title":"Use of 35 words for evaluation of hearing loss in signal-to-babble ratio: a clinic protocol","volume":"42","author":"Wilson","year":"2005","journal-title":"J. Rehabil. Res. Dev."},{"issue":"6","key":"10.1016\/j.heares.2021.108209_bib0092","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1523\/JNEUROSCI.3960-15.2016","article-title":"Increased synchrony and bursting of dorsal cochlear nucleus fusiform cells correlate with tinnitus","volume":"36","author":"Wu","year":"2016","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.heares.2021.108209_bib0093","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/01.STR.29.1.12","article-title":"Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial","volume":"29","author":"Yamaguchi","year":"1998","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.heares.2021.108209_bib0094","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neulet.2005.01.047","article-title":"Ebselen prevents noise-induced excitotoxicity and temporary threshold shift","volume":"380","author":"Yamasoba","year":"2005","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.heares.2021.108209_bib0095","doi-asserted-by":"crossref","first-page":"598","DOI":"10.7326\/0003-4819-141-8-200410190-00007","article-title":"Effectiveness of primary care-based vestibular rehabilitation for chronic dizziness","volume":"141","author":"Yardley","year":"2004","journal-title":"Ann. Intern. Med."}],"container-title":["Hearing Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378595521000435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378595521000435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:58:18Z","timestamp":1759921098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378595521000435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":95,"alternative-id":["S0378595521000435"],"URL":"https:\/\/doi.org\/10.1016\/j.heares.2021.108209","relation":{},"ISSN":["0378-5955"],"issn-type":[{"value":"0378-5955","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of ebselen for the treatment of sensorineural hearing loss and tinnitus","name":"articletitle","label":"Article Title"},{"value":"Hearing Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heares.2021.108209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108209"}}